Phase I Trial of SAR245408 (S08), a Pan-Phosphatidylinositol 3 Kinase (PI3K) Inhibitor, in Patients with Chronic Lymphocytic Leukemia (CLL) and LymphomaJennifer R. Brown, Farrukh T. Awan, Joanne Lager et al.|Blood|2011Cited by 11